Purpose: To identify risk factors for VNS-induced arrhythmia.
INTRODUCTION
Vagus nerve stimulation (VNS) therapy has been widely used. The most common stimulation-associated side effects are voice alteration, hoarseness, throat and neck pain, headache, cough, and dyspnea [1] . The most severe side effects of VNS therapy are bradycardia and cardiac arrest [2] . We encountered a patient with symptomatic bradycardia due to VNS who underwent cardiac pacemaker (PM) implantation that resolved symptomatic bradycardia. We hypothesized that risk factors for such bradycardia may exist, identification of which would help prevent VNS-induced critical arrhythmia.
METHODS
A search for medical papers on PubMed and Google Scholar using the key words "vagus nerve stimulation", "arrhythmia", and "bradycardia" revealed 14 papers with 21 patients, not including our case.
We compared patients with VNS-induced arrhythmia (arrhythmia group, n=22) and patients without such arrhythmia (control group, n=29). The control group comprised all other patients who underwent VNS implantation in our facility between 2011 and 2014 and had not shown any VNS-induced arrhythmia for more than four years. Inclusion criteria for the control group were: 1) > 4 years follow-up; and 2) surgery performed by the same surgeon (AF).
We statistically compared each factor between groups, using the Mann-Whitney rank-sum test and Fisher's exact test as appropriate. Statistical significance was set at p < 0.05. All analyses were performed using Sigma Plot 14 software (Systat Software, San Jose, CA).
A C C E P T E D M A N U S C R I P T

CASE REPORT
A 43-year-old, right-handed man was admitted to our hospital due to loss of consciousness (LOC). At 17 years old, he had experienced right temporal lobe contusion in a motor cycle accident. The patient started to exhibit impaired awareness seizures with or without secondary generalization from 27 years old, followed by psychiatric symptoms and accompanying delusions and hallucinations from his early thirties. Temporal lobe epilepsy and epileptic psychosis were diagnosed in his early thirties and had been followed by a local psychiatrist. As his epilepsy had been drug-resistant, he was referred to our hospital. He was on topiramate at 200 mg/day, carbamazepine (CBZ) at 400 mg/day and risperidone at 4 mg/day when he visited our At this time, the patient was on levetiracetam (LEV) at 3000 mg/day, CBZ at 400 mg/day and risperidone at 4 mg/day. Since implantation of the PM, the patient has remained free of sudden LOC.
Ethics approval
Written informed consent for publication of case details was obtained from our patient.
This study was approved by the ethics committee at Seirei Hamamatsu General
Hospital.
RESULTS
All clinical data are shown in Table 1 . The 22 patients [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] in the arrhythmia group 
DISCUSSION
From our data and another study into the relationship between VNS and sudden unexpected death in epilepsy [15] , the VNS dose and duty cycle themselves did not seem directly linked to lethal arrhythmia. This stimulation might not directly affect cardiac conduction, but indirect stimulation through the central nervous system to the conduction system might cause bradycardia. If the bradycardia had been induced by direct stimulation, the control group (which showed both higher output current and higher duty cycle) would have shown a higher prevalence of arrhythmia. Ali et al. [5] speculated that activation of the afferent pathway for the left vagal nerve has wide-ranging effects on multiple systems and pathways, and may result in activation of multiple other synaptic pathways with influences on cardiac rhythm. This might be the
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T mechanism underlying arrhythmia.
In this study, the arrhythmia group was significantly older than the control group.
Arrhythmia associated with vasovagal syncope is reportedly seen most often in the adult population [16, 17] . Increased hypersensitivity of the vagus nerve induced symptomatic arrhythmia even with not particularly strong stimulations in our case. We therefore have to monitor patients with VNS over the long term and in the case of repetitive syncopal events seen, not only ECG but also Holter ECG and loop recorder are recommended [18] .
This was a case study with a review of published reports. Future work is needed in the form of a multi-center study with a greater number of patients.
Conclusion
Even though arrhythmia could be critical, most cases were treated as new-onset epileptic seizures with adjustment of ASDs for a period. To prevent lethal cardiac asystole in VNS treatment, clinicians should be alert to the possibility of new-onset syncopal events differing from habitual seizures.
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